Qilu Pharmaceuticals
Hao Liu has extensive experience in the field of translational medicine and science. Hao is currently the Vice President and Head of Translational Medicine at Qilu Pharmaceuticals since August 2022. Prior to that, they held the position of Director and Head of Translational Science at Legend Biotech starting in May 2021. From July 2017 to May 2021, they worked as an Associate Director in Translational Science at Incyte. Before that, they served as a Senior Research Scientist in Translational Medicine at MedImmune from May 2015 to July 2017. Hao Liu also worked as a Senior Research Scientist at Centocor JNJ from April 2008 to May 2015 and as a Principle Analyst at BMS from November 2006 to April 2008.
Hao Liu holds a Bachelor of Science degree in Biochemistry from Hebei University. Hao also obtained a Master's degree in Plant Molecular Biology from Peking University. Additionally, they completed a Ph.D. in Molecular Genetics at Rutgers University and a Master of Science degree in Computer Science, also from Rutgers University.
This person is not in any offices
Qilu Pharmaceuticals
Established in 1958 and headquartered in Jinan, China, Qilu Pharmaceuticals is a large and comprehensive pharmaceutical company specializing in R&D, manufacture, sales and international trade of both APIs and drug products.